Ermias Diro
Dados Biográficos
| ID | 7005387 |
|---|---|
| NOME | Ermias Diro |
| PRENOMES | Ermias |
| SOBRENOME | Diro |
| ASSINATURA | DIRO E |
| AFILIAÇÕES | University of Gondar |
| ORCID | 0000-0002-3595-6323 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 4 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 4 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2015 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2026 |
| ÍNDICE H | 0 |
Visceral leishmaniasis elimination in South Asia
In 2005, the governments of Bangladesh, India and Nepal, in partnership with the WHO, started the Kala-azar Elimination Programme (KEP) to reduce the incidence of visceral leishmaniasis to below 1 new case in 10 000 population. The target was achieved by Bangladesh in 2017 and validated in 2023. The KEP has demonstrated that, through a concerted approach and public–private partnership, it is possible to eliminate visceral leishmaniasis from the w…
Adherence to chronic hepatitis B screening guidelines for persons from intermediate to high prevalence Countries
Sponsorship in non-commercial clinical trials
BACKGROUND: Non-commercial clinical research plays an increasingly essential role for global health. Multiple partners join in international consortia that operate under the limited timeframe of a specific funding period. One organisation (the sponsor) designs and carries out the trial in collaboration with research partners, and is ultimately responsible for the trial's scientific, ethical, regulatory and legal aspects, while another organizatio…
Prevalence of tuberculosis and treatment outcome among university students in Northwest Ethiopia
The prevalence of TB is higher in comparison to the national figure among students in University of Gondar. Active surveillance systems could be important to get a clear picture of the TB situation in such settings. Assessing the factors associated with the high prevalence to gear the TB control strategy could also be essential
Sem obras proeminentes nesta página.
Sponsorship in non-commercial clinical trials
BACKGROUND: Non-commercial clinical research plays an increasingly essential role for global health. Multiple partners join in international consortia that operate under the limited timeframe of a specific funding period. One organisation (the sponsor) designs and carries out the trial in collaboration with research partners, and is ultimately responsible for the trial's scientific, ethical, regulatory and legal aspects, while another organizatio…
Prevalence of tuberculosis and treatment outcome among university students in Northwest Ethiopia
The prevalence of TB is higher in comparison to the national figure among students in University of Gondar. Active surveillance systems could be important to get a clear picture of the TB situation in such settings. Assessing the factors associated with the high prevalence to gear the TB control strategy could also be essential
Adherence to chronic hepatitis B screening guidelines for persons from intermediate to high prevalence Countries
Visceral leishmaniasis elimination in South Asia
In 2005, the governments of Bangladesh, India and Nepal, in partnership with the WHO, started the Kala-azar Elimination Programme (KEP) to reduce the incidence of visceral leishmaniasis to below 1 new case in 10 000 population. The target was achieved by Bangladesh in 2017 and validated in 2023. The KEP has demonstrated that, through a concerted approach and public–private partnership, it is possible to eliminate visceral leishmaniasis from the w…
Medicine (3 obras) · Public health (3 obras) · Family medicine (2 obras) · Internal Medicine (2 obras) · Pathology (2 obras) · Pediatrics (2 obras) · Retrospective cohort study (2 obras) · Biostatistics (1 obras) · Business (1 obras) · Clinical trial (1 obras)